 |
|
|
|
|
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Bloechl R. on NEWS: Research Brief: Blocking Apoptosis Delays ALS in Mice, Reyes et al. report that the mitochondrial apoptotic pathway crucially contributes to... 21 Oct 2010.
|
|
|
 |
|
|
Bloechl R. on NEWS: Honolulu: The Missing Link? Tau Mediates Aβ Toxicity at Synapse, The important result by Ittner et al. that post-synaptic targeting of the Src kinase Fyn depends... 9 Aug 2010.
|
|
|
|
|
|
Bloechl R. on PAPER: Renner M. et al., 2010, The very interesting report by Renner et al. demonstrates Aβ-induced clustering of mGluR5... 29 Jun 2010.
|
|
|
|
|
|
Bloechl R. on PAPER: Li Z. et al., 2010, The neurotrophin receptor p75 has been reported to facilitate NMDAR-dependent long-term... 16 Jun 2010.
|
|
|
|
|
|
Bloechl R. on PAPER: Emmanouilidou E. et al., 2010, In their discussion, Emmanouilidou et al. consider the possibility that the degenerative effects... 16 Jun 2010.
|
|
|
|
|
|
Bloechl R. on PAPER: Morales R. et al., 2010, The discussion about pathogenic interactions between different amyloidogenic proteins and their... 8 Apr 2010.
|
|
|
|
|
|
Bloechl R. on PAPER: Knowles JK. et al., 2009, Knowles et al. show that Aβ oligomers bind to the neurotrophin receptor p75 (cf. Costantini et... 7 Dec 2009.
|
|
|
|
|
|
Bloechl R. on PAPER: Bengoechea TG. et al., 2009, The controversy about the truncated s-p75 isoform, which is reflected in Dr. Bothwell's comment,... 23 Jun 2009.
|
|
|
|
|
|
Bloechl R. on NEWS: Peripheral p75 Protects Against Aβ Toxicity, The paper reports that aggregated Aβ reduces neurite outgrowth from p75-deficient sympathetic... 5 May 2009.
|
|
|
|
|
|
Bloechl R. on PAPER: Fombonne J. et al., 2009, The paper reports a direct interaction of p75 and APP that crucially involves the first... 24 Apr 2009.
|
|
|
|
|
|
Bloechl R. on NEWS: Keystone: Partners in Crime—Do Aβ and Prion Protein Pummel Plasticity?, Lauren et al. report that Aβ oligomers bind to PrPc and that the detrimental effect of Aβ on... 24 Mar 2009.
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our latest Webinar: 
